SULMEPRIM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sulmeprim, and what generic alternatives are available?
Sulmeprim is a drug marketed by Usl Pharma and is included in two NDAs.
The generic ingredient in SULMEPRIM is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sulmeprim
A generic version of SULMEPRIM was approved as sulfamethoxazole; trimethoprim by SUN PHARM INDUSTRIES on August 25th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SULMEPRIM?
- What are the global sales for SULMEPRIM?
- What is Average Wholesale Price for SULMEPRIM?
Summary for SULMEPRIM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 161 |
| Clinical Trials: | 1 |
| DailyMed Link: | SULMEPRIM at DailyMed |
Recent Clinical Trials for SULMEPRIM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Roswell Park Cancer Institute | Phase 4 |
| National Cancer Institute (NCI) | Phase 4 |
US Patents and Regulatory Information for SULMEPRIM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Usl Pharma | SULMEPRIM | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 070063-001 | Aug 1, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Usl Pharma | SULMEPRIM PEDIATRIC | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 070064-001 | Aug 1, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
